Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Mylan Appoints Emerging Markets President | Contract Pharma
Breaking News, Promotions & Moves

Mylan Appoints Emerging Markets President

Bamzai to head commercial ops in India

Rakesh Bamzai has been appointed president, India Commercial and Emerging Markets at Mylan, Inc. Mr. Bamzai has more than 20 years of experience in the Indian and global biopharmaceutical industry.
 
Prior to joining the company, he served as president of marketing at Biocon, where he had overall responsibility for APIs and branded formulations and managed a team of more than 2,000 people across functional areas and geographies. He also oversaw strategic partnerships that enabled the company to gain greater global access and market penetration for its biopharmaceuticals business. Mr. Bamzai also led Biocon’s branded formulations initiatives, building many successful brands across therapies in India and Gulf Cooperation Council states.
 
Mylan president Rajiv Malik, said, “We were extremely pleased when Rakesh asked to join our company. Many of us at Mylan have had a firsthand opportunity to work with Rakesh over the course of our strategic partnership with Biocon and have observed his strong business and marketing acumen, his strategic insight and outstanding leadership skills. In this new role overseeing all of Mylan’s commercial operations in India and emerging markets, we believe that Rakesh will add significant value to Mylan.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters